Related Experiment Video
Updated: Dec 5, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Plasma glycemic measures and fecundability in a Singapore preconception cohort study
See Ling Loy1, Chee Wai Ku2, Ada En Qi Lai3
1Department of Reproductive Medicine, KK Women's and Children's Hospital, Singapore; Duke-NUS Medical School, Singapore; Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A∗STAR), Singapore.
Objective:
To examine the association between plasma glycemia in women attempting to conceive and fecundability, as measured by time to pregnancy.
Design:
Prospective preconception population-based study.
Setting:
Hospital.
Patient(S):
Asian preconception women, 18-45 years old, attempting conception for ≤12 cycles at study entry.
Intervention(S):
None.
Main Outcome Measure(S):
We ascertained time to pregnancy within a year of glycemic assessment in menstrual cycles. We estimated fecundability ratios (FRs) and 95% confidence intervals using discrete-time proportional hazards models, adjusting for age, ethnicity, education, body mass index, and cycle regularity and accounting for left truncation and right censoring.
Result(S):
We studied a population sample of 766 women from the Singapore Preconception Study of Long-Term Maternal and Child Outcomes prospective cohort. Compared with women with normoglycemia, women with dysglycemia (prediabetes and diabetes, defined by the American Diabetes Association) had a lower FR (0.56). Compared with the respective lowest quintiles, women in the highest quintile of fasting glucose (≥5.1 mmol/L) had an FR of 0.60, while women in the highest 2-hour postload glucose quintile (≥6.9 mmol/L) had an FR of 0.66. Overall, the FRs decreased generally across the range of fasting and 2-hour plasma glucose. Glycated hemoglobin was not associated with fecundability.
Conclusion(S):
Increasing preconception plasma glucose is associated with reduced fecundability, even within the normal range of glucose concentrations.
Clinical Trial Registration Number:
NCT03531658.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

